Get Healthy!

GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers

A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.

HealthDay
Health News is provided as a service to Hudson Pharmacy site users by HealthDay. Hudson Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.